Press Release

In-vitro Toxicology Testing Market to grow with a CAGR of 9.66% through 2028

Growing demand of the safety of new drugs and Environmental monitoring are the major drivers for the Global In-Vitro Toxicology Testing Market.


According to TechSci Research report, “In-Vitro Toxicology Testing Market –Global Industry Size, Share, Trends, Competition, Opportunity and Forecast, 2018-2028”, the Global Dyes Market stood at USD 16.09 Billion in 2022 and is anticipated to project robust growth in the forecast period with a CAGR of 9.66% through 2028. This can be ascribed to collaborations and partnerships among leading companies with a diverse approach to merge the expertise of individual companies and to strengthen their position in the market.


In-vitro toxicology testing is a scientific approach used to assess the potential toxicity of chemicals, drugs, consumer products, and other substances using isolated cells, tissues, or cellular components outside of a living organism. Significant growth in the healthcare industry across the globe represents one of the key factors creating a positive outlook for the market. Furthermore, the increasing demand for Public Health and Consumer Safety and media and advocacy industries is also driving the market growth. These apparel industries are consumer-based, contributing to the economy by providing trade along the technology and applications. The demand for in-vitro toxicology testing is prevalent across several industries and sectors where safety assessment, risk evaluation, and regulatory compliance are crucial.


Therefore, the increasing demand in the pharmaceutical and biotechnology industry will drive the Toxicology Testing market. In-vitro toxicology testing is extensively used in drug discovery and development to assess the safety and potential toxicity of new drug candidates. It helps identify compounds with adverse effects, optimize lead candidates, and reduce the likelihood of unexpected toxicity during clinical trials. Moreover, leading players operating in the industry are focusing on product innovations to offer a better customer experience. They are also engaging in partnerships and collaborations to increase their brand presence. Apart from this, Chemical manufacturers rely on in-vitro toxicology testing to evaluate the safety of new chemicals, industrial materials, and chemical products. This includes assessing potential hazards, such as cytotoxicity, genotoxicity, and carcinogenicity, before these substances are introduced into the market.


Browse over XX market data Figures and spread through XX Pages and an in-depth TOC on "Global In-vitro Toxicology Testing Market.”


Moreover, In-vitro toxicology testing is essential for evaluating the safety of cosmetics, skincare products, and other personal care items. It helps ensure that these products do not cause adverse effects on skin, eyes, or other tissues. This, along with the rising demand for reduced animal testing, is driving the market. Government initiatives play a significant role in shaping the development, adoption, and regulatory acceptance of in-vitro toxicology testing methods globally. These initiatives aim to promote alternatives to animal testing, improve safety assessment practices, and enhance human and environmental health protection. There is a growing emphasis on Human-relevant models within the healthcare industry, There is a strong emphasis on developing and using human-relevant models, such as human-derived cells and tissues, to improve the accuracy and relevance of toxicity assessments. These models better predict human responses and reduce reliance on animal testing.


Additionally, the Registration, Evaluation, Authorization, and Restriction of Chemicals (REACH) regulation in the European Union promotes the use of alternative testing methods, including in-vitro methods, to assess the safety of chemicals. It encourages the development and validation of alternative approaches and provides regulatory incentives for their adoption. The Tox21 program, led by the National Toxicology Program (NTP), the National Institutes of Health (NIH), and the U.S. Environmental Protection Agency (EPA), aims to improve chemical safety testing through high-throughput in-vitro and computational approaches. It focuses on identifying potential health risks associated with environmental chemicals. These projects serve as tangible examples of innovation and encourage other industry players to embrace similar approaches. Through strategic partnerships, brands, manufacturers, and Testing players can collaborate to implement sustainable practices.


The Charles River laboratories international, Inc. (CRL) announced today the scheduled opening of the Charles River accelerator and development lab, Charles River Accelerator®, in Seattle and Philadelphia. Charles River Accelerator® Seattle is Charles River’s latest investment in Seattle. The company’s first facility opened in 2021 in response to the rapidly expanding city’s position as a leading life sciences center with strong start-up and business growth. CRADL® Seattle is set to open this September and responds to the growing demand for more dynamic vivarium space, as well as in vivo on-demand study support services. As a leading contract vivarium provider, Charles River Laboratories International (CRL) is committed to expanding the capacity of its biopharmaceutical facilities to meet the growing demands of the industry.


However, complexity of biological system and long term and chronic effects are expected to slow down the growth of the market in the coming years.


The Global In-vitro Toxicology Testing Market segmentation is based on Technology, Application, Method, End-User, By Company, and Region.


Some of the major companies operating in the Global In-vitro Toxicology Testing Market include:

  • Charles River Laboratories International, Inc.
  • SGS S.A.
  • Merck KGaA
  • Eurofins Scientific
  • Abbott Laboratories
  • Laboratory Corporation of America Holdings
  • Evotec S.E.
  • Thermo Fisher Scientific, Inc.
  • Quest Diagnostics Incorporated
  • Agilent Technolgies, Inc.
  • Catalent, Inc.


Download Free Sample Report

Customers can also request for 10% free customization on this report.


“Certain regions, particularly the North-America, are projected to exert significant demand for In-Vitro Toxicology Testing worldwide. The growth in the competitive landscape and the presence of well-established companies in the market, committed to enhancing their technological advancement each year, are expected to contribute to a remarkable growth of the Global In-Vitro Toxicology Testing Market in the forecast period," said Mr. Karan Chechi, Research Director with TechSci Research, a research-based Global management consulting firm.


In-vitro Toxicology Testing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented By Technology (Cell Culture Technology, High Throughput Technology, Molecular Imaging, OMICS Technology), By Application (Systemic Toxicology, Dermal Toxicity, Endocrine Disruption, Occular Toxicity, Others), By Method (Cellular Assay, Biochemical Assay, In-Silico, Ex-Vivo), By End-User (Pharmaceutical Industry, Cosmetics & Household Products, Academic Institutes & Research Laboratories, Diagnostics, Chemicals Industry, Food Industry), By Region, Competition
has evaluated the future growth potential of Global In-vitro Toxicology Testing Market and provides statistics & information on market size, structure, and future market growth. The report intends to provide innovative market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in Global In-vitro Toxicology Testing Market.


Contact

Mr. Ken Mathews

708 Third Avenue,

Manhattan, NY,

New York – 10017

Tel: +1-646-360-1656

Email: [email protected]

Website: https://www.techsciresearch.com

Relevant News